chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt faint / faintness / pervasive feeling of fainting; nauseous; had a fever; body aches; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in the left arm on 04Mar2021 11:00 (at the age of 70-years-old; lot number: EN6199, expiration date not reported) as dose 1, single and via an unspecified route of administration on 25Mar2021 13:54 (at the age of 70-years-old; lot number: EP7534, expiration date not reported) as dose 2, single both for COVID-19 immunization. The patient has no relevant medical history and no concomitant medications. It was reported that the patient was really healthy with normal blood pressure and no other medical complications. The patient has no additional vaccines administered on same date of the Pfizer Suspect product. The patient had no prior vaccinations within 4 weeks. The patient had no family medical history relevant to the adverse events. It was reported that the patient had all of the shots of Pfizer COVID Vaccines. The patient experienced she felt faint, faintness, pervasive feeling of fainting, nauseous, had a fever and body aches on an unspecified date after receiving the first 1st dose and 2nd dose of the vaccine. The patient described the events as follows: stated that she did have a little fever and body aches and so forth which was the normal reaction except she also had the pervasive feeling of fainting and the nausea which was abnormal. It was reported that there was absolutely nothing different in the patient's routine for food or any medications and that she currently does not take any medication and therefore attributed the reported events to the Pfizer COVID Vaccine. The patient underwent lab test and procedures which included blood pressure: normal on an unspecified date. The outcome of the events faint, faintness, pervasive feeling of fainting, nauseous and fever was recovered on an unspecified date; reported as the faintness and nausea did pass, and fever and nausea were not ongoing, and they resolved the day after the vaccine doses were administered that same day. The outcome of body aches was unknown.
Pt vaccinated with Varivax 1/19/94. Today has full blown case of chicken pox with well over 100 lesions.
5/29/09 Approx. 10:45 AM - Pt fainted outside clinic in the front passenger side of her car. Revived when her arm was shook by nurse. Ambulance was called by front desk staff. B/P- 98/60 P-62 R- 12 - C/O nausea, nurse cooled her with cool washcloth, Husband was with her he stated he seen her make jerking movements before passing out. Ambulance arrived and transported her to hospital.
Dizziness, Headache, Myalgia, Fever, last night Temp 101.5F, then splitting headaches,bodyaches, dizziness, fatigue, malaise; some relief with tylenol Narrative:
Site: Bruising at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild
After each dose the patient had an infection from the injection site to the knee that lasted 3 weeks; Patient had redness in both legs; she received the MODERNA shot on her side; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INFECTION (After each dose the patient had an infection from the injection site to the knee that lasted 3 weeks), ERYTHEMA (Patient had redness in both legs) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (she received the MODERNA shot on her side) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy, LISINOPRIL and METOPROLOL for Blood pressure, SIMVASTATIN (ZOCOR) for Cholesterol, MELATONIN for Difficulty sleeping, FUROSEMIDE (LASIX [FUROSEMIDE]) for Diuretic therapy, SECNIDAZOLE (SENEX [SECNIDAZOLE]) for Panic attacks, ALPRAZOLAM for Panic disorder, COLECALCIFEROL (VITAMIN D3), VITAMIN B12 [VITAMIN B12 NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (she received the MODERNA shot on her side). On an unknown date, the patient experienced INJECTION SITE INFECTION (After each dose the patient had an infection from the injection site to the knee that lasted 3 weeks) and ERYTHEMA (Patient had redness in both legs). At the time of the report, INJECTION SITE INFECTION (After each dose the patient had an infection from the injection site to the knee that lasted 3 weeks), ERYTHEMA (Patient had redness in both legs) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (she received the MODERNA shot on her side) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had 50 unknown antibiotics to treat the infection.
NEUROLOGICAL ISSUES; INFLAMMATORY RESPONSE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced neurological issues, and inflammatory response. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from neurological issues, and inflammatory response. This report was non-serious.
Pt had routine administration of Hepatitis A (1st dose) vaccine. Within 2 hours started having chills and fever. Denies being sick before vaccine administration. Seen back in clinic at 1300 the temp was 102.5. No other symptoms. Sent home with Ibuprofen. 24 hours later temp 101.1. Still no other symptoms. Instructed to continue Ibuprofen and return in 24 hours. 48 hours after injection temp at 98. Pt had previously had entire hepatitis B series and all other childhood and military vaccines without reaction.
01/04/22 presents to "sleeping more often" "not been able to walk very well secondary to weakness in his legs bilaterally" "diarrhea for the last 3 days". PMHx of "hypertension, chronic kidney disease on hemodialysis" "BPH, urinary retention secondary to prostatic hyperplasia, and recent clavicle fracture"
Very sore arm by the evening of the vaccination. Next day had redness, swelling, pain distal to injection sites, but pt. states was closest to the flu shot. (Flu shot given anteriorly, PPSV posteriorly approx. 1 inch apart in the largest part of deltoid). States at its worst, the pain was 6-7 on scale of 0-10 with 10 most severe. At 74 hours (today at 12 noon, she rates pain at 1-2). Photographs of the affected limb taken at office today. Very red and still warm. Pt took acetaminophen for pain and used cool compresses. Pt was encouraged to call allergist, and advised I could mail photos if allergist wanted them.
Pain at injection site post 4 hours of shot. Muscle pain with chills and sweating about 12 hours later, but short lived.  Treated with Tylenol. General fatigue
fever, spike in temp; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever, spike in temp) and CHILLS (chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever, spike in temp) and CHILLS (chills). At the time of the report, PYREXIA (fever, spike in temp) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Reporter stated that her husband took Spikevax on a day before reporting and stated that with the previous doses, both she and he had experienced a fever, spike in temp, and chills with all doses which lasted a short while but did not last. Patient reported that with Spikevax, he did not.  The patient did not have lot number information for their Moderna vaccines: initial doses and all boosters.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-745401 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-745401:Wife case (Same reporter diferrent patients)
Injection was given IM route in deltoid muscle on 1/6/17. As of today, injection site is still painful.
red ring after 9 days size of a silver dollar; felt like it made them itch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch). At the time of the report, INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided.
After administering vaccine, patient immediately grew faint, a red bump appeared where the vaccine was administered, patient started shaking uncontrollably, pulse light and thready, had patient put her head between her legs, watched injection site for increasing size, color, etc. and asked patient if she was having trouble breathing, her throat felt like it was closing and her lips or any part of her face felt numb, she denied all, said everything was blurry and that I seemed miles away.  Could not hold her head up and shook as she laid her head upon her arms on the table.  Called 911 and EMT's arrived, pt was feeling better and refused to go to the hospital.  Advised patient to buy Benadryl and keep an eye on the injection site and in the event of any rash, trouble breathing, etc, to call 911 or go to the emergency room right away.
Extreme body aches, fever, headache, fatigue, nausea, vomiting.
My mother died. A week later a report was out that if someone had covid twice they shouldn?t get the vaccine. She was your lab rat
Information has been received from an advanced practice registered nurse concerning a 78 year old postmenopausal female, weight 142lb, height 59.5 inches, with osteoarthritis, hearing deficit (left), hypertension, incontinence and cholesterolaemia who on 29-JAN-2008 was vaccinated in the arm with the second dose of VARIVAX (Merck) (lot# 659154/1495U) instead of zoster vaccine live (Merck) by mistake.  Concomitant therapy included LIPITOR, OXYBUTYNIN, ASPIRIN, "OCCIVIT", multi-vitamins and LISINOPRIL-HCTZ (MSD).  The reporter stated the error may have due to a storage issue because the products were stored in the same bag in the freezer.  This was not a product confusion.  As of 19-JUN-2008, no adverse events were noted.  Additional information is not expected.
Lymph node swelling; ymph node swelling in left breast; lymph node swelling in left side of neck; couldn't lift left arm; A spontaneous report was received from a Consumer concerning a 50-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events lymph node swelling left side of body, lymph node swelling in left breast, lymph node swelling in left side of neck, couldn't lift left arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 010M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events lymph node swelling left side of body . On an unknown date, the patient experienced the events lymph node swelling in left breast . On an unknown date, the patient experienced the events lymph node swelling in left side of neck . On an unknown date, the patient experienced the events couldn't lift left arm.  Treatment details included Ice and heat compresses, ibuprofen  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, lymph node swelling left side of body, lymph node swelling in left breast, lymph node swelling in left side of neck, couldn't lift left arm was not reported.
Inflammation at vaccination site; Arm vaccinated sore; Fever; lethargy; aches in joints; chills; light-headedness; congestion; headache; soreness; This is a spontaneous report contactable consumer or other non HCP (patient, self-reporting).  A 27-year-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6206 and expiration dates was not reported), via an unspecified route of administration in left arm on 03Mar2021 at 14:30 as second dose, single for COVID-19 immunisation. The patients medical history included diabetes, PCOS, sciatica, scoliosis, psoriasis on an unknown date. Concomitant medication included LPRYNA 0.02MG two weeks. The historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EM9810 and expiration dates was not reported), via an unspecified route of administration in left arm on 10Feb2021 at 14:30 first dose single for COVID-19 immunisation. On 03-MAR-2021 23:45 patient experienced Inflammation at vaccination site. Arm Vaccinated sore. Fever, lethargy, Aches in joints, chills, light-headedness, Congestion, headache, soreness. Patient did not have any vaccines prior to four weeks. Facility type vaccine: School or student health clinic. There was no treatment given for the adverse events. No COVID prior vaccination and did not tested COVID post vaccination. Outcome of the events were recovering.    No follow-up attempts are possible. No further information is expected
0.2mL of Pfizer-BioNTech given to patient under the age of 5 years of age. The recommended age for Pfizer-BioNTech is 5-11 Years of age. The patient remained in the office for 1 hour and showed no signs of adverse reaction physically or mentally after the 1 hour. The patient was allowed to go home. Medical staff to call the parents on 11-9-21 and follow up with the patient.  Office medical incident report has been documented. All medical staff will verify the right patient, the right time, the right vaccine (and diluent), the right dosage, theright route, needle, and technique, the right injection site, right documentation, as well as confirm the age of the patient before drawing up the vaccine and before administering the vaccine.
procedure in which his heart was cut from top to bottom/pacemaker dependent; fast heart rate; afib; red dots on both of his arms; rash on both arms; dizzy; sick; very weak/no energy; hard time walking; cannot do the simplest of tasks; flutter; A spontaneous report was received from a Consumer concerning herself, a 57-year-old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, fast heart rate, cardiac pacemaker dependent, atrial fibrillation, red dots on both of his arms, rash on both arms, dizziness, sick, Atrial flutter, very weak and no energy, hard time walking, and cannot do the simplest of tasks.  The patient's medical history included atrial fibrillation and had a pacemaker placed about 8-9 months ago.  Products known to have been used by the patient, within two weeks prior to the event were blood pressure medication, antiarrhythmics.  On 01 Mar 2021, prior to the onset of events, the patient received their first of the two planned doses of mRNA-1273 (Lot number: 030m20a) via unknown route for prophylaxis of COVID-19 infection.  On 01 Mar 2021, after vaccination, the patient developed red dots on both of his arms. For next two days, the patient had rash on both arms, was dizzy, felt sick, developed fast heart rate; went to hospital twice for heart rate either 07 Mar 2021 or 13 Mar 2021.During first visit to hospital, fast rate was brought under control, while in the second visit, the patient had a procedure in which his heart was cut from top to bottom and was made pacemaker dependent. The atrial fibrillation could not be controlled for 26 hours and had a flutter which was not identified and could not be controlled. Flutter returned after stopping amlodipine and hence patient was restarted on amlodipine. The patient now feels very weak, has a hard time walking, has no energy, cannot do the simplest of tasks, still experiences fast heart rate and flutter every now and then.   No Laboratory investigations were provided. The Treatment information included pacemaker, amlodipine.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, fast heart rate, cardiac pacemaker dependent, atrial fibrillation, red dots on both of his arms, rash on both arms, dizziness, sick, atrial flutter, very weak and no energy, hard time walking, cannot do the simplest of tasks were unknown.
Since getting vaccinated I have been having reproductive issues for the first time in my life, including heavy blood clots and painful cramping during periods. I waited to report because I hoped the issues would go away after my first few cycles post-vaccine but they have not.   I also am experiencing cramping sometimes between periods and also twice passed blood clots between periods, which had never happened before.   Anecdotally I have two female friends who are also experiencing reproductive issues (clotting, cramping, heavy periods, changes in cycle length and duration). Each of us have tried discussing it with medical professionals, who have so far said that the cramping and blood clots show correlation but not causation. I disagree.   We are women in our 30s and 40s who have had our cycles for a decades now. We know our bodies and are confident that these issues are vaccine-related.   Before marketing these as safe to children and especially  to young girls, please please please can you try to find out what is causing the clotting and cramping?
I now have a 3/8-inch circular scar on my arm where the injection was administered.
Slept and nursed well during the night, post vax, but the whole next day, was irritable, barely slept, barely nursed and had 1 period when she lay awake but was abnormally still. Seen in ER in the evening; irritable, drowsy but nursed some and interacted well. Did not behave normally again until 09:00 on 3/25/01.
April 8 got flu like symptoms- body aches, April 8th thru 14th- got fever, red arm and hot , rash on arm, hard lump on arm got fever of  101 and then went to ER worried it could be cellulitis.  Was at hospital late on the 13th and left early am on 14th.  Was told to take Benadryl.  Later on the 14th got rash all over face, chest, arms.  On 18th was very week and dizzy and was prescribed prednisone.  Her Dr. told her not to get the second dose of Moderna
Arm soreness; Swelling at injection site; Whole body achiness; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th October 2020, the patient received the 1st dose of Shingrix. On 30th October 2020, less than a day after receiving Shingrix, the patient experienced general body pain, pain in arm and injection site swelling. On an unknown date, the outcome of the general body pain, pain in arm and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the general body pain, pain in arm and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, after vaccination, the patient experienced whole body achiness that presented in vaccination night but it resolved by day 4. The patient had arm soreness and swelling at injection site after the first dose that resolved within 4 days. The reporter consented to follow up. For the tolerence of dose 2 refer case US2021002010, reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021002010:Same reporter
10 days after second Pfizer shot, tinnitus in right ear. Has not stopped in 35 days.
This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), intramuscular (left arm) on 08Jan2021 15:00 at single dose for Covid-19 immunization. The patient's medical history included skin cancer removal in September and Covid (reported as prior vaccination); no known allergies. Concomitant medications included spironolactone, ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE), desvenlafaxine succinate (PRISTIQ), escitalopram, sambucus nigra (ELDERBERRY), and apple cider vinegar (gummies), and daily vitamin (unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient is not pregnant. The patient reported that she had flu symptoms all weekend after she got the vaccine. It included chills, fatigue, headache, dizziness and she had bad muscle cramps in calves. She then started having pain in lymph nodes under left arm a couple days ago. The adverse events start date was reported as 09Jan2021. There was no treatment received for the adverse events. The outcome of events was recovered with sequel (reported as recovered with lasting effects) on an unspecified date. The patient has not been tested for COVID-19 since the vaccination.
At 3am the next morning she awoke with severe aches, pain, & chills. Exact thing happened w/second shot on 6/3/19, Lot #LE85F.
I developed daily headaches for 1.5 weeks followed by intermittent headaches for another 1.5 weeks. I had skin discoloration   and moderate irritation at the injection site for 5 weeks.
fever-low grade temp of 99.4, sneezing, congestion, runny nose, nonproductive cough, body aches, sinus congestion, nasal congestion, post nasal drainage starting on 10/26/21
I had a sore arm and fatigue after receiving Dose 5 Moderna vaccine. I was exposed to COVID-19 while on vacation. I tested positive for COVID-19 on 04/20/2023. I had a virtual visit with my provider and got a prescription for Paxlovid. I tolerated the medication without any complications. As of today, I get fatigued easier than before.
Day of- sore arm. Day 2- painful and hard to move left arm. Lethargy/sore throat/cough/headache and then spiked a fever of 100.4 starting at 10pm that lasted until 2-3am until I took Tylenol. Day 3- woke up and fever resolved. Still have cough, muscle aches, and slight headache